Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Balchem Corporation

Stage 2 · Advancing · week 12

As of Oct 22, 2026, Balchem is in Stage 2, the uptrend phase, now in week 12 (since Aug 5, 2026). It closed at $173.23, 5.5% below its 52-week high and above its 200-day average, which is rising.

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant… More about the company

$173.23
+1.43% today
$5.5B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 19 in Specialty Chemicals · #1 of 76 in Materials

Is BCPC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 18w
S2 27w
S4 21w
S2 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 6w → S3 3w → S4 7w → S1 2w → S2 18w → S3 8w → S2 27w → S3 5w → S4 5w → S1 6w → S4 11w → S1 2w → S4 21w → S1 6w → S2 14w → S3 12w → S4 1w → S3 1w → S2 11w current
Total tracked: 165 weeks across 19 stage runs.

BCPC among Specialty Chemicals30th of 62 by relative strength

All 62 →
Stocks in Specialty Chemicals ranked by relative strength, with stage and one-month change
#StockStageRS1M
1SSLStage 2 · wk 798+22.2%
2ALTOStage 4 · wk 498−3.8%
3CLMTStage 2 · wk 5897−9.3%
4KROStage 2 · wk 1090−9.4%
5LYBStage 2 · wk 787+9.0%
6ASHStage 2 · wk 2086+6.6%
7IFFStage 2 · wk 2185+9.5%
8KOPStage 3 · wk 485−11.9%
…30BCPCStage 2 · wk 1263+3.0%
vs 52W High
-5.5%
$146.46 lo$183.26 hi
5.5% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 12
1w13w26w
Week 12, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
2.6%
200 DMA: $168.92 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
2.32x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+3.0%
3M
+6.4%
6M
-1.9%
YTD
+12.5%
1Y
+11.1%
Scan Membership
Breakout Watch
Latest: 2024-07-02
9 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 12 · Vol 2.32x
2026-10-21S2
Wk 11 · Vol 0.39x
2026-10-20S2
Wk 11 · Vol 1.61x
2026-10-19S2
Wk 11 · Vol 1.78x
2026-10-16S2
Wk 11 · Vol 0.97x
2026-10-15S2
Wk 11 · Vol 1.72x
2026-10-14S2
Wk 10 · Vol 1.23x
2026-10-13S2
Wk 10 · Vol 1.18x
2026-10-12S2
Wk 10 · Vol 0.85x
2026-10-09S2
Wk 10 · Vol 1.63x
2026-10-08S2
Wk 10 · Vol 1.03x
2026-10-07S2
Wk 9 · Vol 2.38x
Moving averages & range
50 DMA
$171.13
200 DMA
$168.92
52W High
$183.26
52W Low
$146.46
5D Low
$170.42
Resistance levels (recent highs)
20d High
$173.23
60d High
$181.28
120d High
$181.28
250d High
$183.26
Next resistance
+4.6%
to 60d High
P/E (TTM)
33.9
Forward 27.5
Earnings Growth (YoY)
+18.8%
Revenue +11.2%
ROE
+12.8%
Profit margin +15.1%
Dividend Yield
0.56%
P/B 4.2

Balchem: quick answers

What stage is Balchem in?

As of Oct 22, 2026, Balchem (BCPC) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 5, 2026 and is in week 12. What the four stages mean

Is Balchem in an uptrend?

Yes. Balchem is in a Stage 2 uptrend. It trades 2.6% above its 200-day average, which is rising.

How far is Balchem from its 52-week high?

Balchem closed at $173.23 on Oct 22, 2026, 5.5% below its 52-week high of $183.26. Its 52-week low is $146.46.

How has Balchem performed over the past year?

As of Oct 22, 2026, Balchem is up 11.1% over the past year and up 12.5% so far in 2026.

Which sector and industry is Balchem in?

Balchem is in the Specialty Chemicals industry, part of the Materials sector.

About this companyMaterials· Specialty Chemicals

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.